Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Skin symptoms can indicate endocrine disorders and have various treatments.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Overweight women with PCOS are more likely to have excess male hormones.

Women with PCOS may be more likely to have gum disease than healthy women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.